An MS patient loses trust when she finds out her doctor is paid by drug companies

Health Affairs

Volumn 30, Issue 12, 2011, Pages 2449-2452

  Wolston, Maran ^a,b,c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b Normandale Community College   (United States)

^c METROPOLITAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLATIRAMER; NATALIZUMAB;

BRAIN; BREATHING; CASE REPORT; DRUG INDUSTRY; DRUG SCREENING; DRUG WITHDRAWAL; HEALTH INSURANCE; HUMAN; INJECTION SITE PAIN; INTERPERSONAL COMMUNICATION; MEDICAL CARE; MEDICAL ETHICS; MULTIPLE SCLEROSIS; NEUROLOGIST; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT INFORMATION; PATIENT PARTICIPATION; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; QUALITY OF LIFE; SPINAL CORD; TRUST; UNITED STATES; VISUAL DISORDER;

ANTIBODIES, MONOCLONAL, HUMANIZED; CLINICAL TRIALS AS TOPIC; CONFLICT OF INTEREST; DISCLOSURE; DRUG INDUSTRY; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MINNESOTA; MULTIPLE SCLEROSIS; PATIENT PROTECTION AND AFFORDABLE CARE ACT; PEPTIDES; PHYSICIANS; UNITED STATES;

EID: 84855713623     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.2011.0094     Document Type: Note

References (0)